• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过其在阿片受体上的结合亲和力和选择性特征来验证 17-环丙甲基-4,5α-环氧-3,14β-二羟基-6β-[(4'-吡啶基)羧酰胺基]吗啡烷衍生物的 3-羟基的作用。

Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors.

机构信息

Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, 800 E Leigh Street, Richmond, VA 23298, United States.

Center for Substance Abuse Research and Department of Pharmacology, Lewis Katz School of Medicine, Temple University, 3500 North Broad Street, MERB 851, Philadelphia, PA 19140, United States; Beijing Key Laboratory of Neuropsychopharmacology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.

出版信息

Bioorg Chem. 2021 Apr;109:104702. doi: 10.1016/j.bioorg.2021.104702. Epub 2021 Feb 9.

DOI:10.1016/j.bioorg.2021.104702
PMID:33631465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8009840/
Abstract

In the present study, the role of 3-hydroxy group of a series of epoxymorphinan derivatives in their binding affinity and selectivity profiles toward the opioid receptors (ORs) has been investigated. It was found that the 3-hydroxy group was crucial for the binding affinity of these derivatives for all three ORs due to the fact that all the analogues 1a-e exhibited significantly higher binding affinities compared to their counterpart 3-dehydroxy ones 6a-e. Meanwhile most compounds carrying the 3-hydroxy group possessed similar selectivity profiles for the kappa opioid receptor over the mu opioid receptor as their corresponding 3-dehydroxy derivatives. [S]-GTPγS functional assay results indicated that the 3-hydroxy group of these epoxymorphinan derivatives was important for maintaining their potency on the ORs with various effects. Further molecular modeling studies helped comprehend the remarkably different binding affinity and functional profiles between compound 1c (NCP) and its 3-dehydroxy analogue 6c.

摘要

在本研究中,考察了一系列环氧吗啡喃衍生物中 3-羟基基团在与阿片受体(ORs)结合亲和力和选择性特征方面的作用。研究发现,由于所有类似物 1a-e 与相应的 3-去羟基类似物 6a-e 相比,均表现出显著更高的结合亲和力,因此 3-羟基基团对于这些衍生物与所有三种 ORs 的结合亲和力至关重要。同时,大多数带有 3-羟基基团的化合物在与κ型阿片受体相比时,对μ型阿片受体具有相似的选择性特征,就像它们相应的 3-去羟基衍生物一样。[S]-GTPγS 功能测定结果表明,这些环氧吗啡喃衍生物的 3-羟基基团对于维持其在 ORs 上的效力非常重要,且具有不同的作用。进一步的分子建模研究有助于理解化合物 1c(NCP)与其 3-去羟基类似物 6c 之间显著不同的结合亲和力和功能特征。

相似文献

1
Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors.通过其在阿片受体上的结合亲和力和选择性特征来验证 17-环丙甲基-4,5α-环氧-3,14β-二羟基-6β-[(4'-吡啶基)羧酰胺基]吗啡烷衍生物的 3-羟基的作用。
Bioorg Chem. 2021 Apr;109:104702. doi: 10.1016/j.bioorg.2021.104702. Epub 2021 Feb 9.
2
Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.17-环丙甲基-3,14β-二羟基-4,5α-环氧-6β-[(4'-吡啶基)羧酰胺基]吗啡喃衍生物作为μ阿片受体拮抗剂的构效关系研究。
Bioorg Med Chem Lett. 2011 Sep 15;21(18):5625-9. doi: 10.1016/j.bmcl.2011.06.135. Epub 2011 Jul 18.
3
Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands.17-环丙基甲基-3,14β-二羟基-4,5α-环氧-6α-(异喹啉-3'-甲酰胺基)吗啡喃类似物作为阿片受体配体的设计、合成及药理学特性研究
Bioorg Med Chem. 2015 Apr 15;23(8):1701-15. doi: 10.1016/j.bmc.2015.02.055. Epub 2015 Mar 6.
4
Structure activity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) analogues as potent opioid receptor ligands: preliminary results on the role of electronic characteristics for affinity and function.17-环丙甲基-3,14β-二羟基-4,5α-环氧-6α-(异喹啉-3'-羧酰胺)吗啡喃(NAQ)类似物作为有效阿片受体配体的构效关系研究:电子特性对亲和力和功能影响的初步结果。
Bioorg Med Chem Lett. 2013 Sep 15;23(18):5045-8. doi: 10.1016/j.bmcl.2013.07.043. Epub 2013 Jul 31.
5
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.第三代 17-环丙甲基-3,14β-二羟基-4,5α-环氧-6β-[(4'-吡啶基)羧酰胺基]吗啡喃(NAP)衍生物的设计、合成及生物评价作为μ/κ 阿片受体双重选择性配体。
J Med Chem. 2019 Jan 24;62(2):561-574. doi: 10.1021/acs.jmedchem.8b01158. Epub 2019 Jan 11.
6
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy.去甲羟吗啡吲哚、17-取代-6,7-脱氢-4,5α-环氧-3,14-二羟基-6,7:2',3'-吲哚吗啡喃中的N-烷基和N-烯基取代基对阿片受体亲和力、选择性和效力的影响。
J Med Chem. 2001 Apr 26;44(9):1471-4. doi: 10.1021/jm000511w.
7
Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.设计、合成及生物评价 17-环丙甲基-3,14β-二羟基-4,5α-环氧-6β-[(4′-吡啶基)羰酰胺基]吗啡喃衍生物作为外周选择性μ阿片受体激动剂。
J Med Chem. 2012 Nov 26;55(22):10118-29. doi: 10.1021/jm301247n. Epub 2012 Nov 9.
8
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion.17-环丙基甲基-3,14β-二羟基-4,5α-环氧-6β-(4'-吡啶甲酰胺基)吗啡喃(NAP)以偏向方式调节μ阿片受体。
ACS Chem Neurosci. 2016 Mar 16;7(3):297-304. doi: 10.1021/acschemneuro.5b00245. Epub 2016 Jan 8.
9
Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies.4,6'-环氧吗啡喃衍生物的合成及其药理学
Bioorg Med Chem. 2008 Apr 15;16(8):4304-12. doi: 10.1016/j.bmc.2008.02.082. Epub 2008 Feb 29.
10
Probes for narcotic receptor mediated phenomena. 18. Epimeric 6 alpha- and 6 beta-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5 alpha-epoxymorphinans as potential ligands for opioid receptor single photon emission computed tomography: synthesis, evaluation, and radiochemistry of [125I]-6 beta-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5 alpha-epoxymorphinan.麻醉受体介导现象的探针。18. 作为阿片受体单光子发射计算机断层扫描潜在配体的差向异构6α-和6β-碘-3,14-二羟基-17-(环丙基甲基)-4,5α-环氧吗啡喃:[125I]-6β-碘-3,14-二羟基-17-(环丙基甲基)-4,5α-环氧吗啡喃的合成、评价及放射化学
J Med Chem. 1992 Jul 24;35(15):2826-35. doi: 10.1021/jm00093a016.

引用本文的文献

1
Conformational Plasticity Enhances the Brain Penetration of a Metabolically Stable, Dual-Functional Opioid-Peptide CycloAnt.构象可塑性增强了代谢稳定的双功能阿片肽环抗的脑穿透性。
Int J Mol Sci. 2024 Oct 23;25(21):11389. doi: 10.3390/ijms252111389.
2
Blocking potential metabolic sites on NAT to improve its safety profile while retaining the pharmacological profile.阻断 NAT 上的潜在代谢位点,在保留药理学特征的同时提高其安全性。
Bioorg Chem. 2024 Jul;148:107489. doi: 10.1016/j.bioorg.2024.107489. Epub 2024 May 22.
3
NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties.

本文引用的文献

1
Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.计算洞察结构相似的双位点调节剂在μ阿片受体上差异化变构调节的分子机制。
J Comput Aided Mol Des. 2020 Aug;34(8):879-895. doi: 10.1007/s10822-020-00309-x. Epub 2020 Mar 19.
2
Potent, Efficacious, and Stable Cyclic Opioid Peptides with Long Lasting Antinociceptive Effect after Peripheral Administration.具有强大、有效和稳定的外周给药后具有持久抗伤害作用的环阿片肽。
J Med Chem. 2020 Mar 12;63(5):2673-2687. doi: 10.1021/acs.jmedchem.9b01963. Epub 2019 Dec 27.
3
NCP是一种κ和μ阿片受体双重激动剂,是一种强效抗炎性疼痛镇痛药,无强化或厌恶特性。
J Pharmacol Exp Ther. 2024 Mar 15;389(1):106-117. doi: 10.1124/jpet.123.001870.
4
Characterization of a Potential KOR/DOR Dual Agonist with No Apparent Abuse Liability via a Complementary Structure-Activity Relationship Study on Nalfurafine Analogues.通过对纳呋拉啡类似物的互补结构-活性关系研究,鉴定一种潜在的 KOR/DOR 双重激动剂,且无明显滥用倾向。
ACS Chem Neurosci. 2022 Dec 21;13(24):3608-3628. doi: 10.1021/acschemneuro.2c00526. Epub 2022 Nov 30.
5
Structural Characterization of KOR Inactive and Active States for 3D Pharmacology and Drug Discovery.三维药理学和药物发现中 KOR 无活性和活性状态的结构特征。
Handb Exp Pharmacol. 2022;271:41-64. doi: 10.1007/164_2021_461.
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists.
阐明具有肽和小分子激动剂的活性 δ-阿片受体晶体结构。
Sci Adv. 2019 Nov 27;5(11):eaax9115. doi: 10.1126/sciadv.aax9115. eCollection 2019 Nov.
4
Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators.双价生物等排概念在高效阿片受体调节剂的设计与发现中的应用。
J Med Chem. 2019 Dec 26;62(24):11399-11415. doi: 10.1021/acs.jmedchem.9b01767. Epub 2019 Dec 10.
5
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder.17-环丙甲基-3,14-二羟基-4,5-环氧-6-[(3'-氟-4'-吡啶基)乙酰氨基]吗啡烷(NFP)作为一种双重选择性 MOR/KOR 配体的药理学特性及其在治疗阿片类药物使用障碍中的潜在应用。
Eur J Pharmacol. 2019 Dec 15;865:172812. doi: 10.1016/j.ejphar.2019.172812. Epub 2019 Nov 16.
6
Hot topics in opioid pharmacology: mixed and biased opioids.阿片类药物药理学的热点问题:混合和偏倚阿片类药物。
Br J Anaesth. 2019 Jun;122(6):e136-e145. doi: 10.1016/j.bja.2019.03.006. Epub 2019 Apr 19.
7
Repeated Administration of Norbinaltorphimine Produces Cumulative Kappa Opioid Receptor Inactivation.反复给予诺宾那托啡产生累积性κ阿片受体失活。
Front Pharmacol. 2019 Feb 6;10:88. doi: 10.3389/fphar.2019.00088. eCollection 2019.
8
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment.17-环丙甲基-3,14β-二羟基-4,5α-环氧-6α-(吲哚-7-羧酰胺基)吗啡烷(NAN)作为一种新型阿片受体调节剂用于治疗阿片类药物使用障碍的特征。
ACS Chem Neurosci. 2019 May 15;10(5):2518-2532. doi: 10.1021/acschemneuro.9b00038. Epub 2019 Feb 21.
9
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.第三代 17-环丙甲基-3,14β-二羟基-4,5α-环氧-6β-[(4'-吡啶基)羧酰胺基]吗啡喃(NAP)衍生物的设计、合成及生物评价作为μ/κ 阿片受体双重选择性配体。
J Med Chem. 2019 Jan 24;62(2):561-574. doi: 10.1021/acs.jmedchem.8b01158. Epub 2019 Jan 11.
10
Untangling the complexity of opioid receptor function.解析阿片受体功能的复杂性。
Neuropsychopharmacology. 2018 Dec;43(13):2514-2520. doi: 10.1038/s41386-018-0225-3. Epub 2018 Sep 24.